Company / Operating Cash Flow
Oncology Institute, Inc. Operating Cash Flow History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$26.5M
FY2025
5-year range
-$61.8M / $508.0K
FY2021-FY2025
Trend
+26.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$62M to -$27M over the past 2 years.
Based on SEC 10-K filings.
-$27M in FY2025.
Improved from -$62M to -$27M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 26.9% year-over-year.
- Peak operating cash flow was recorded in FY2021.
- Lowest operating cash flow in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$26.5M | +26.9% |
| FY2024 | -$36.3M | +41.2% |
| FY2023 | -$61.8M | -89.0% |
| FY2022 | -$32.7M | -6533.1% |
| FY2021 | $508.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026